Liu, Yu
Zhongnan Hospital of Wuhan University · Hubei Cancer Hospital
3 papers on CoChatORCID 0000-0002-1282-4897
Most cited papers
- Verified
Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak
Dai, M., Liu, D., Liu, M., Zhou, F., Li, G., Chen, Z., Zhang, Z., You, H., Wu, M., Zheng, Q., et al. (2020) · Cancer Discovery
COVID-19 and healthcare impactsCOVID-19 Clinical Research Studies
Cited by 1,589
- Verified
Two-Year Treatment With Denosumab (AMG 162) in a Randomized Phase 2 Study of Postmenopausal Women With Low BMD
Lewiecki, E. M., Miller, P. D., McClung, M. R., Cohen, S. B., Bolognese, M. A., Liu, Y., Wang, A., Siddhanti, S., & Fitzpatrick, L. A. (2007) · Journal of Bone and Mineral Research
Bone health and osteoporosis researchBone health and treatments
Cited by 319
- Verified
Reversing Multidrug Resistance in Caco-2 by Silencing MDR1, MRP1, MRP2, and BCL-2/BCL-xL Using Liposomal Antisense Oligonucleotides
Lo, Y.-L., & Liu, Y. (2014) · PLoS ONE
Drug Transport and Resistance MechanismsNanoparticle-Based Drug Delivery
Cited by 45
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free